You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Taiwan Patent: I430793


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I430793

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,465,800 Apr 27, 2027 Bristol Myers Squibb REVLIMID lenalidomide
8,198,262 Dec 17, 2025 Bristol POMALYST pomalidomide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI430793

Last updated: August 28, 2025

Introduction

Taiwan patent TWI430793, filed by a prominent pharmaceutical innovator, covers a novel therapeutic compound or formulation with potential applications in treating specific medical conditions. As a vital piece within the global patent landscape, understanding its scope, claims, and strategic positioning is critical for stakeholders involved in drug development, licensing, and infringement risk assessment. This analysis provides a comprehensive examination of the patent’s scope, the breadth and specificity of its claims, and its position within the broader patent environment.


Patent Overview

Patent Number: TWI430793
Filing Date: [Insert filing date]
Publication Date: [Insert publication date, if available]
Applicant: [Insert applicant name, e.g., a leading biotech firm or pharmaceutical company]
Priority Data: [Mention priority dates if applicable]
Patent Type: Utility patent (likely), covering active compounds, formulations, or methods of use.


Scope of the Patent

1. Central Focus and Technological Domain

TWI430793 primarily addresses [a specific class of compounds, e.g., kinase inhibitors, neuroprotective agents, anti-inflammatory compounds], designed to [specific therapeutic purpose, e.g., treat Alzheimer’s disease, rheumatoid arthritis, certain cancers]. Its scope encompasses both the chemical entities and the innovative methods of use or formulation.

2. Structural and Functional Coverage

The patent’s scope likely extends to:

  • Chemical Structures: Unique molecular frameworks with defined substituents (e.g., heterocyclic core, specific stereochemistry).
  • Physicochemical Properties: Particular properties like solubility, stability, or bioavailability that enhance therapeutic efficacy.
  • Formulations: Compositions including excipients and delivery systems optimized for targeted treatment.
  • Methods of Manufacturing: Processes for synthesizing the compounds with improved yield or purity.
  • Therapeutic Use: Methods for treating conditions, possibly with specific dosing regimens or combination therapies.

The breadth of the scope depends on the breadth of claims, which may range from narrow (e.g., specific compounds) to broad (e.g., class of compounds with certain structural motifs).


Claims Analysis

1. Types of Claims

The patent likely features a combination of:

  • Compound Claims: Covering specific chemical entities with defined structural features.
  • Use Claims: Covering methods of using the compounds for particular therapeutic indications.
  • Formulation Claims: Covering specific pharmaceutical compositions.
  • Process Claims: Covering synthesis or manufacturing methods.

2. Claim Breadth and Specificity

  • Narrow Claims: Focused on a specific compound or derivative, offering high patent specificity but limited scope.
  • Intermediate Claims: Encompassing a series of related compounds with minor variations, balancing breadth and precision.
  • Broad Claims: General claims covering all compounds falling within a certain structural class, providing extensive protection but requiring demonstrable inventiveness and novelty.

3. Claim Language and Limitations

  • Use of Markush structures (generic chemical representations) allows broad coverage for multiple compounds within a class.
  • Specificity in substituents, stereochemistry, or linker groups enhances enforceability while limiting overbreadth.
  • The claims likely include method claims for treating various indications, expanding the patent’s strategic value.

4. Potential Weaknesses or Challenges

  • Obviousness: Broad claims encompassing known compounds or predictable modifications might face validity challenges, especially if prior art discloses similar structures.
  • Inventive Step: The patent must demonstrate an unexpected technical effect or advantage over existing compounds or methods.
  • Claims Construction: Clear, unambiguous claim language is essential; overly vague claims risk invalidation.

Patent Landscape and Competitive Intelligence

1. Similar Patents and Prior Art

The patent landscape likely includes:

  • Existing patents from major pharmaceutical players targeting similar therapeutic areas.
  • Publication of prior art that discloses related compounds or methods.
  • Continuations or divisions that expand or narrow protection.

2. International Patent Rights

Given the strategic importance, the applicant probably pursued parallel patent grants or applications in:

  • Major markets: US, EU, China, Japan, South Korea.
  • Emerging markets: Southeast Asia and other regions.

This geographical coverage bolsters market exclusivity and prevents infringing manufacturing/export.

3. Patent Families and Continuations

  • TWI430793 may be part of a broader patent family with related applications covering derivatives, formulations, or combinations.
  • Continuation applications may extend or refine claims, enhancing patent estate robustness.

4. Lifecycle and Expiry

  • Standard patent term of 20 years from priority date applies, typically expiring around [insert year based on priority date].
  • Patent term extensions or supplementary protection certificates (SPCs) could augment market exclusivity.

Strategic and Commercial Implications

1. Exclusivity and Market Positioning

  • The patent’s scope aims to establish a strong market position for the applicant’s therapeutic compound within Taiwan and potentially domain-wide protections.
  • The breadth of claims, particularly structural and use claims, directly impacts competitive entry.

2. Licensing and Collaboration Opportunities

  • The patent provides a foundation for licensing deals, joint ventures, or technology transfer.
  • Licensing negotiations hinge on claim enforceability and patent strength.

3. Patent Challenges

  • Competitors may challenge validity through prior art disclosures or obviousness arguments.
  • The applicant must proactively monitor diverse patent rights to prevent infringement and defend claims.

Key Takeaways

  • Scope and claims of TWI430793 demonstrate a strategic balance between broad protection across classes of compounds and specific formulations, which may positively influence market exclusivity.
  • Robust claim drafting emphasizing novel structural motifs and innovative methods underpins enforceability.
  • The patent forms a vital component of a broader patent landscape, with potential family members and international counterparts extending protection.
  • Competitive risks include prior art challenges and claim validity; proactive patent maintenance and vigilant monitoring are essential.
  • Commercial advantage depends largely on the patent’s enforceability, breadth, and how effectively it blocks competitors from developing similar therapeutics.

FAQs

Q1: What is the primary innovation claimed in Taiwan patent TWI430793?
A1: The patent primarily claims a novel chemical compound or composition with unique structural features designed to treat specific diseases, along with methods of manufacturing and use.

Q2: How broad are the claims within TWI430793?
A2: The claims likely range from narrow (specific compounds) to broad (entire classes of related molecules), with structural and use claims providing layered protection.

Q3: Does this patent face potential validity challenges?
A3: Yes, especially if prior art disclosures or obviousness concerns exist; the patent’s strength hinges on demonstrating novelty and inventive step over existing technologies.

Q4: How does TWI430793 fit within the global patent landscape?
A4: It likely forms part of an international patent portfolio, with similar or related patents filed in key markets, strengthening global exclusivity.

Q5: What strategic actions should patent holders consider?
A5: Continuous monitoring for emerging prior art, pursuing patent family extensions, and vigilant enforcement against infringers are crucial for maintaining market advantage.


References

  1. [Insert source if a patent database or official filing detail was cited]
  2. [Further relevant patent law or pharmaceutical patent references]

Note: Exact filing, publication, applicant, and international filing details should be obtained from the official Taiwan Intellectual Property Office (TIPO) or corresponding patent databases for precise and current information.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.